Sensus Healthcare (SRTS) Cost of Revenue (2016 - 2025)

Sensus Healthcare's Cost of Revenue history runs 10 years deep, the most recent figure standing at -$6.0 million for Q4 2025.

• In Q4 2025, Cost of Revenue rose 6.03% year-over-year to -$6.0 million; the TTM figure through Dec 2025 stood at $4.7 million (up 264.83% YoY), while the FY2025 annual figure was $6.5 million, up 31.04% from the prior year.
• Cost of Revenue was -$6.0 million for Q4 2025 at Sensus Healthcare, down from $4.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $6.6 million in Q4 2021 to a low of -$6.4 million in Q4 2024.
• Historically, Cost of Revenue has averaged $1.4 million across 5 years, with a median of $1.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue sank 1130.08% in 2024, then soared 342.97% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $6.6 million in 2021, then plunged by 75.95% to $1.6 million in 2022, then plunged by 60.34% to $625000.0 in 2023, then tumbled by 1130.08% to -$6.4 million in 2024, then rose by 6.03% to -$6.0 million in 2025.
• The last three Cost of Revenue figures came in at -$6.0 million (Q4 2025), $4.2 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.